BROWN RUDNICK LLP for HOSPIRA, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to prescription drug shortages: --P.L. 111-148: Patient Protection and Affordable Health Care Act provisions relating to biosimilar products.; --H.R. 1919: Safeguarding America's Pharmaceuticals Act of 2013; --H.R. 3204: The Drug Quality and Safety Act; --S. 957: The Drug Supply Chain Security Act; --S. 232: Medical Device Access and Innovation Protection Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN New | Secr for Congr & Intgv Affairs, Dept. Labor 01-02 |
| LISA LAYMAN | SPA, Sen Stabenow(05-07) |
| HENRY W MENN | Min SD & Counsel, Cmte on Vet Affairs (04) |
Pharmacy PHA
-- Issues relating to generic drug labeling -- S. 959: The Pharmaceutical Quality, Security and Accountability Act -- H.R. 3204: The Compounding Clarity Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN New | — |
| HENRY W MENN | — |
Budget/Appropriations BUD
-- S. 1413: FDA User Fee Protection Act -- H.R. 2725: "FDA Safety Over Sequestration Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN New | — |
| HENRY W MENN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.